Nanostar technology at the NWU brings hope for early disease detection
At the North-West University (NWU), research is more than publishing, it is about transforming lives. This is the vision driving a team at the Centre for Human Metabolomics (CHM), where scientists developed a nanostar-based reagent that could revolutionise how rare diseases such as galactosemia are detected. The reagent promises significant advantages over conventional spherical gold nanoparticles, and demonstrates high sensitivity detection in biosensors, colorimetric assays, surface-enhanced Raman spectroscopy (SERS) and molecular diagnostics.